No Detail Found!

Peroxisome Proliferator-Activated Receptor Gamma Agonists Modulate High-Fat Diet- and Carbon Tetrachloride-Induced Non-Alcoholic Fatty Liver Disease Pathophysiology and Transcriptional Expression of Inflammatory Markers in a Murine Model

Author(s)
Syeda Momna Ishtiaq Institute of Physiology and Pharmacology, University of Agriculture,Faisalabad-38040, Punjab, Pakistan
Junaid Ali Khan Institute of Physiology and Pharmacology, University of Agriculture,Faisalabad-38040, Punjab, Pakistan
Faqir Muhammad Institute of Physiology and Pharmacology, University of Agriculture,Faisalabad-38040, Punjab, Pakistan
Muhammad Shahid Department of Biochemistry, University of Agriculture,Faisalabad-38040, Punjab,Pakistan
Abstract
The objectives of the present study were to investigate the effect of induced activation of peroxisome proliferator-activated receptor gamma (PPAR?) through ligands, rosiglitazone (RG), kaempferol (KEM) and GW9662 (GW) in pathophysiological alterations and inflammation by regulating the expression of PPAR?-regulated genes in a rat model of nonalcoholic fatty liver disease (NAFLD). Male wistar rats (N=45) were fed high fat diet (HFD; 35%) in combination with single dose of carbon tetrachloride (CCl4; 0.5ml/kg/intraperitoneally) to induce NAFLD. The effects of synthetic PPAR? agonist; RG (15mg/kg) and PPAR? antagonist; GW (10mg/kg) were evaluated in comparison with putative natural ligand; KEM (12mg/kg). Co-administration of HFD and CCl4 mimicked NAFLD as evident by elevation of hepatic injury markers and lipid profile in serum. The results of AST/ALT ratio and AST to platelet ratio index indicated NAFLD without advanced liver disease. RG and KEM, in contrast to GW, countered NAFLDassociated effects by ameliorating hepatic injury markers, insulin resistance and lipid profile. KEM and RG treatment increased the expression of IL-33, an antiinflammatory cytokine, while the expression of TNFa, a pro-inflammatory cytokine was non-significantly decreased. The results suggested that PPAR? activation by agonist ligands might contribute towards amelioration of NAFLD-associated pathophysiology of metabolic syndrome and hepatic inflammation through regulation of IL-33 and TNFa.
Publication Details
Page(s) 292-299
Published Journal: Pakistan Veterinary Journal, Volume: 42, Issue: 3, Year: 2022

Request the full text from PASTIC

Keywords
NAFLD, Liver diseases, Kaempferol, CCl4, Rosiglitazone, PPAR gamma
0

Citations

0

Downloads

145

Views